Danaher Corporation (DHR)
Cash ratio
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 4,615,000 | 1,528,000 | 2,957,000 | 1,993,000 | 2,078,000 | 2,627,000 | 2,374,000 | 7,031,000 | 5,864,000 | 12,277,000 | 8,575,000 | 7,379,000 | 5,995,000 | 5,150,000 | 3,984,000 | 3,717,000 | 2,586,000 | 2,552,000 | 7,322,000 | 6,330,000 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 6,807,000 | 6,324,000 | 6,792,000 | 6,645,000 | 6,798,000 | 7,339,000 | 6,701,000 | 7,778,000 | 8,274,000 | 9,367,000 | 8,404,000 | 8,730,000 | 8,389,000 | 8,002,000 | 7,556,000 | 7,547,000 | 8,140,000 | 7,257,000 | 6,825,000 | 6,824,000 |
| Cash ratio | 0.68 | 0.24 | 0.44 | 0.30 | 0.31 | 0.36 | 0.35 | 0.90 | 0.71 | 1.31 | 1.02 | 0.85 | 0.71 | 0.64 | 0.53 | 0.49 | 0.32 | 0.35 | 1.07 | 0.93 |
December 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($4,615,000K
+ $—K)
÷ $6,807,000K
= 0.68
Peer comparison
Dec 31, 2025
Company name
Symbol
Cash ratio
Danaher Corporation
DHR
0.68
Agilent Technologies Inc
A
0.76
Thermo Fisher Scientific Inc
TMO
0.67